We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Early Menopause Poses Health and Mortality Risks

By HospiMedica International staff writers
Posted on 07 May 2012
Menopause before age 47 significantly increases the risk of osteoporosis, fragility fractures, and premature mortality over the next 30 years, according to a new study.

Researchers at Skåne University Hospital (Malmö, Sweden) conducted a prospective population-based observational study involving 390 white north European women aged 48 recruited in 1977 for the Malmo perimenopausal study. More...
The women were divided into two categories; women who started menopause before age 47 and women who started the menopause at age 47 or later. An initial bone mineral density (BMD) was measured, and at the age of 77, all eligible women were re-measured for BMD. The prevalence of osteoporosis was determined using dual-energy X-ray absorptiometry (DXA).

The results showed that at age 77, 298 women were still alive, while 92 had died; of these, 100 had relocated or declined further participation, leaving 198 women to attend the follow-up measurement. In all, 56% of women with early menopause had osteoporosis, in comparison with 30% of women with late menopause. Women who started the menopause early were also found to have a higher risk of mortality (52.4%), compared to 35.2% in the late menopause group. The fragility fracture incidence rate was also higher--44.3% in the early menopause group compared to 30.7% in the late menopause group. The study was published early online on April 25, 2012, in BJOG.

“The results of this study suggest that early menopause is a significant risk factor for osteoporosis, fragility fracture, and mortality in a long-term perspective,” concluded lead author orthopedic surgeon Ola Svejme, MD, and colleagues. “The higher fracture risk in women with early menopause in the current study is probably to some extent mediated by a lower bone mineral density, as the early-menopause cohort had a significantly higher risk of osteoporosis at age 77. To our knowledge, this is the first prospective study with a follow-up period of more than three decades.”

Menopause is a term used to describe the permanent cessation of the primary functions of the human ovaries, including estradiol and progesterone production, part of the female body's endocrine system of hormone production. After menopause, estrogen continues to be produced in other tissues, notably the ovaries, but also in bone, blood vessels and even in the brain; but the dramatic fall in circulating estradiol levels at menopause impacts many tissues, from bone to brain to skin.

Related Links:

Skåne University Hospital




Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Vessel Sealing Instrument
ERGOseal
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.